GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Return-on-Tangible-Equity

Shanghai INT Medical Instruments Co (HKSE:01501) Return-on-Tangible-Equity : 11.96% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Shanghai INT Medical Instruments Co's annualized net income for the quarter that ended in Dec. 2024 was HK$195.1 Mil. Shanghai INT Medical Instruments Co's average shareholder tangible equity for the quarter that ended in Dec. 2024 was HK$1,631.3 Mil. Therefore, Shanghai INT Medical Instruments Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 was 11.96%.

The historical rank and industry rank for Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity or its related term are showing as below:

HKSE:01501' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.62   Med: 12.82   Max: 23.23
Current: 12.82

During the past 9 years, Shanghai INT Medical Instruments Co's highest Return-on-Tangible-Equity was 23.23%. The lowest was 9.62%. And the median was 12.82%.

HKSE:01501's Return-on-Tangible-Equity is ranked better than
72.03% of 758 companies
in the Medical Devices & Instruments industry
Industry Median: 2.605 vs HKSE:01501: 12.82

Shanghai INT Medical Instruments Co Return-on-Tangible-Equity Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Return-on-Tangible-Equity Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only 10.52 11.71 9.62 11.22 12.96

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.10 11.37 10.54 13.51 11.96

Competitive Comparison of Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity falls into.


;
;

Shanghai INT Medical Instruments Co Return-on-Tangible-Equity Calculation

Shanghai INT Medical Instruments Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=204.901/( (1552.568+1610.507 )/ 2 )
=204.901/1581.5375
=12.96 %

Shanghai INT Medical Instruments Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=195.12/( (1652.175+1610.507)/ 2 )
=195.12/1631.341
=11.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Shanghai INT Medical Instruments Co  (HKSE:01501) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Shanghai INT Medical Instruments Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
Executives
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Wang Kai 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Orbimed Capital Llc 2102 Investment manager
Zhao Wei 2202 Interest of your spouse
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other
Shanghai Kindly Holding Group Co., Ltd. 2201 Interest of corporation controlled by you
Worldwide Healthcare Trust Plc 2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines